Yijun Zheng | Medicine | Best Researcher Award

Posted on by Forensic Scientist

Mr. Yijun Zheng | Medicine | Best Researcher Award

The Second Hospital & Clinical Medical School, Lanzhou University | China

Dr. Zheng Yijun is a dedicated medical researcher currently pursuing a PhD in Surgery at Lanzhou University. With a strong focus on the pharmacological actions of traditional Chinese medicine in cancer treatment, particularly gastric cancer, he has contributed to multiple papers, including two independent SCI publications. Dr. Zheng also serves as a reviewer for high-impact journals like Frontiers in Medicine and International Journal of Clinical Practice. He is actively involved in projects funded by the National Natural Science Foundation of China and collaborates on key provincial research initiatives.

Professional profile👤

Scopus

Strengths for the Awards✨

  • Strong Research Focus: Zheng has a clear focus on the prevention and treatment of gastric cancer through traditional Chinese medicine, a significant and relevant area of study in modern healthcare.

  • Academic Contributions: Zheng has independently authored two SCI papers, one of which has achieved a high citation rate, highlighting the impact of their work in the academic community.

  • Collaborative Research: Zheng has been involved in eight research projects, including two funded by the National Natural Science Foundation of China, which demonstrates involvement in high-impact research.

  • Peer Review Contributions: Serving as a reviewer for reputable journals such as SCI and Frontiers in Medicine showcases the recognition of Zheng’s expertise and their ability to contribute to the broader academic community.

  • Zheng Yijun demonstrates strong academic research in a promising and highly relevant field. With a focus on traditional Chinese medicine for cancer treatment, significant publications, and involvement in prestigious research projects, Zheng is well-positioned for consideration for the “Best Researcher Award.” However, expanding the breadth of their research network, increasing publication output, and gaining editorial experience would help to further solidify their candidacy for this award.

Education 🎓

Dr. Zheng is currently enrolled in the PhD program in Surgery at Lanzhou University. His academic journey is complemented by his extensive participation in research, including a review of Astragalus Polysaccharide’s pharmacological effects, published in Frontiers in Pharmacology. He has independently authored SCI papers that contribute to the field of traditional medicine’s role in cancer treatment.

Experience 💼

Dr. Zheng has participated in over eight research projects, two of which were funded by the National Natural Science Foundation of China. His work spans across the investigation of gastric cancer treatment and the pharmacological effects of traditional Chinese medicine. Additionally, Dr. Zheng has served as a reviewer for multiple high-impact journals, solidifying his expertise and credibility in the field.

Research Interest On Medicine 🔬

Dr. Zheng’s primary research interest is in the prevention and treatment of gastric cancer through traditional Chinese medicine. His research aims to provide a theoretical foundation for incorporating traditional medicine in cancer therapy, with a specific focus on polysaccharides and their pharmacological actions in tumor treatment.

Award 🏆

Dr. Zheng is a nominee for the Best Researcher Award at the Forensic Scientist Awards, due to his significant contributions to the field of medical research, particularly in the application of traditional Chinese medicine for tumor treatment. His innovative work and high citation rate highlight his impact in medical research.

Publications 📚

  1. Zheng Y, Ren W, Zhang L, Zhang Y, Liu D, Liu Y. “A Review of the Pharmacological Action of Astragalus Polysaccharide.” Front Pharmacol. 2020 Mar 24; 11:349. Link

    • Cited by: 348 articles (SCI citation)

  2. Zheng Y, Zhang Y, Wang Z, Guo X, Zhang L, Zhang Y. “Multiple data sets to explore the key molecules and mechanism of lymph node metastasis in gastric cancer.” Discov Oncol. 2025 Apr 24; 16(1):606. Link

    • Cited by: 98 articles (SCI citation)

Conclusion 🌍

Dr. Zheng Yijun is an emerging leader in the field of medical research, particularly in the application of traditional Chinese medicine for cancer treatment. His dedication to advancing the understanding of gastric cancer and its treatment methods has already resulted in significant publications and recognition. As a nominee for the Best Researcher Award, his future in medical research looks promising, with continued contributions to the development of effective cancer therapies.

Pingyu Zhang | Biochemistry | Best Researcher Award

Posted on by Forensic Scientist

Prof. Pingyu Zhang | Biochemistry | Best Researcher Award

Shenzhen University | China

Pingyu Zhang is a distinguished professor and deputy director of the Department of Chemistry at Shenzhen University. She obtained her Ph.D. in 2015 under the mentorship of Professor Hui Chao at Sun Yat-sen University. Following her doctoral studies, she joined the University of Warwick as a Newton Fellow in Professor Peter J. Sadler’s group from 2015 to 2017. Since 2017, she has been a faculty member at Shenzhen University, where she has made significant contributions to the field of chemistry. In recognition of her outstanding research, she was honored as a Young Chang Jiang Scholar by the Ministry of Education in 2023.

Professional profile👤

ORCID

Google Scholar

Scopus

Strengths for the Awards✨

  1. Outstanding Research Contributions

    • Professor Zhang has made significant advancements in the field of metal complex drugs for tumor-driven therapy, particularly in light- and sound-sensitive anti-tumor treatments.
    • Her pioneering work in sonodynamic therapy using metal complexes has opened new avenues for deep-tumor treatment, demonstrating high scientific impact.

  2. Academic Excellence & Recognitions

    • Recognized as a Young Chang Jiang Scholar (2023) by the Ministry of Education, a prestigious honor highlighting her research excellence.
    • Recipient of the Second-Class Natural Science Award of Shenzhen (2023, first contributor) and the Dalton Division Horizon Prize (2022) from the Royal Society of Chemistry.

  3. Research Productivity & Innovation

    • Published over 80 research papers in reputable journals, reflecting her consistent contributions to the scientific community.
    • Holds 18 Chinese invention patents, indicating her strong emphasis on translational research and innovation.

  4. International Experience & Collaborations

    • Gained global exposure through her postdoctoral research as a Newton Fellow at the University of Warwick (2015-2017) under the mentorship of Professor Peter J. Sadler.
    • Established a strong research presence both nationally and internationally, positioning her as a leading scientist in her field.

Education 🎓

Pingyu Zhang completed her Ph.D. in Chemistry at Sun Yat-sen University in 2015 under the guidance of Professor Hui Chao. Her academic journey equipped her with a strong foundation in metal complex chemistry, which later became a cornerstone of her research career.

Experience 💼

Following her Ph.D., Professor Zhang worked as a Newton Fellow at the University of Warwick from 2015 to 2017, collaborating with Professor Peter J. Sadler on groundbreaking research in metal-based therapeutics. In 2017, she joined Shenzhen University as a faculty member, where she currently serves as a distinguished professor and deputy director of the Department of Chemistry. Her leadership and dedication have significantly advanced the department’s research initiatives.

Research Interests On Biochemistry 🌍

Professor Zhang’s research focuses on the fundamental study of metal complex drugs for tumor-driven therapy. She has pioneered the development of light- and sound-sensitive anti-tumor drugs, creating innovative therapeutic strategies. Notably, she was the first to identify the potential application of metal complexes in sonodynamic therapy, a promising approach for treating deep-seated tumors. Her work aims to enhance cancer treatment efficacy while minimizing side effects.

Awards 🏆

  • Young Chang Jiang Scholar, Ministry of Education (2023)
  • Second-Class Natural Science Award of Shenzhen (First Contributor, 2023)
  • Dalton Division Horizon Prize, Royal Society of Chemistry (2022)

Publications 📚

Professor Zhang has published over 80 research papers in prestigious journals and holds 18 Chinese invention patents. Below are some of her notable publications:

  1. Highly stable single Pt atomic sites anchored on aniline-stacked graphene for hydrogen evolution reaction

    • Authors: S Ye, F Luo, Q Zhang, P Zhang, T Xu, Q Wang, D He, L Guo, Y Zhang, …
    • Year: 2019
    • Citations: 474

  2. Highly charged ruthenium (II) polypyridyl complexes as lysosome‐localized photosensitizers for two‐photon photodynamic therapy

    • Authors: H Huang, B Yu, P Zhang, J Huang, Y Chen, G Gasser, L Ji, H Chao
    • Year: 2015
    • Citations: 445

  3. Targeted photoredox catalysis in cancer cells

    • Authors: H Huang, S Banerjee, K Qiu, P Zhang, O Blacque, T Malcomson, …
    • Year: 2019
    • Citations: 398

  4. Advances in the design of organometallic anticancer complexes

    • Authors: P Zhang, PJ Sadler
    • Year: 2017
    • Citations: 392

  5. New designs for phototherapeutic transition metal complexes

    • Authors: C Imberti, P Zhang, H Huang, PJ Sadler
    • Year: 2020
    • Citations: 377

  6. Ruthenium (II) polypyridyl complexes as mitochondria-targeted two-photon photodynamic anticancer agents

    • Authors: J Liu, Y Chen, G Li, P Zhang, C Jin, L Zeng, L Ji, H Chao
    • Year: 2015
    • Citations: 278

  7. Targeting nucleus DNA with a cyclometalated dipyridophenazineruthenium (II) complex

    • Authors: H Huang, P Zhang, B Yu, Y Chen, J Wang, L Ji, H Chao
    • Year: 2014
    • Citations: 230

  8. Redox‐active metal complexes for anticancer therapy

    • Authors: P Zhang, PJ Sadler
    • Year: 2017
    • Citations: 213

  9. Boosting the alkaline hydrogen evolution of Ru nanoclusters anchored on B/N–doped graphene by accelerating water dissociation

    • Authors: S Ye, F Luo, T Xu, P Zhang, H Shi, S Qin, J Wu, C He, X Ouyang, Q Zhang, …
    • Year: 2020
    • Citations: 174

  10. Noncovalent ruthenium (II) complexes–single-walled carbon nanotube composites for bimodal photothermal and photodynamic therapy with near-infrared irradiation

  • Authors: P Zhang, H Huang, J Huang, H Chen, J Wang, K Qiu, D Zhao, L Ji, …
  • Year: 2015
  • Citations: 167

Conclusion 🎯

Pingyu Zhang is a leading researcher in the field of metal-based tumor therapy, with significant contributions to the development of innovative anti-cancer strategies. Through her pioneering work in sonodynamic and photodynamic therapy, she continues to push the boundaries of cancer treatment. Her numerous accolades, high-impact publications, and patents underscore her influence in the scientific community, making her a key figure in advancing metal complex drug research.

Anquan Shang | Medicine | Best Researcher Award

Posted on by Forensic Scientist

Prof. Anquan Shang | Medicine | Best Researcher Award

The Second People’s Hospital of Lianyungang | China

Prof. Anquan Shang is a distinguished Associate Chief Laboratory Technician and Clinical Laboratory Physician with an H-index of 26. At the age of 39, he has made significant contributions to the field of clinical laboratory diagnostics. As a master’s supervisor, he plays a crucial role in mentoring future medical professionals. He is currently affiliated with Shanghai Jiao Tong University and has extensive experience in tumor marker research and clinical diagnostics.

Profile👤

ORCID

Google Scholar

Scopus

Strengths for the Awards✨

  • Strong Research Productivity 

    • H-index of 26, indicating high citation impact.
    • Over 70 SCI and core journal publications as first or corresponding author.
    • Multiple high-impact factor papers in oncology, microbiology, and immunology.

  • Impressive Funding & Grants 

    • Secured multiple national and provincial-level research grants.
    • Led and participated in 13+ major projects in oncology, infection, and precision diagnostics.

  • Leadership & Recognition 

    • Head of key clinical departments and training programs in prestigious hospitals.
    • Recognized in Shanghai and Jiangsu talent programs, highlighting academic excellence.

  • Significant Innovations & Impact 

    • Contributions to liquid biopsy, tumor biomarkers, and infection diagnostics.
    • 5+ patents, demonstrating translational research impact.

  • Professional Network & Influence 

    • Active in national and international research communities.
    • Reviewer and editor for multiple scientific journals.

🎓 Education

His academic journey began with a specialization in medical laboratory technology at Xiangfan Vocational and Technical College (2005-2008). He then pursued a bachelor’s degree in medical laboratory science at Jiangsu University (2011-2014), followed by a master’s degree in clinical laboratory diagnostics at Ningxia Medical University (2014-2017). He furthered his expertise with a Ph.D. in clinical laboratory diagnostics from Tongji University (2017-2020), establishing a strong foundation for his research career.

🏥 Experience

Currently, he is a postdoctoral researcher in clinical laboratory diagnostics at Ruijin Hospital, affiliated with Shanghai Jiao Tong University (2025-present), focusing on tumor biomarker research. Since 2023, he has led the Clinical Laboratory Medicine Department at Lianyungang Second People’s Hospital, a key clinical specialty in Jiangsu Province. Previously, he completed another postdoctoral fellowship at Tongji University (2020-2022), researching tumor microenvironment and biomarkers. His clinical experience spans roles as a laboratory technician at various hospitals between 2008 and 2014, steadily advancing to leadership positions.

🔬 Research Interests On Medicine

His research focuses on:

1️⃣ Tumor immunology 🧬

2️⃣ Infection microecology and immune microenvironment remodeling 🦠

3️⃣ Precision molecular diagnostics for chronic diseases 🏥

4️⃣ Liquid biopsy techniques for early disease detection 💉

🏆 Awards

He has received numerous prestigious awards, including the Yancheng City Natural Science Achievement Award (3 times), the Yancheng Medical New Technology Introduction Award (5 times), and the Huaihai Science and Technology Progress Award (2nd Prize, twice). From 2019-2022, he was consecutively recognized as an Outstanding Young Scientific Researcher by the Shanghai Medical Association Laboratory Medicine Branch.

📚 Publications

  • Title: Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p-TGF-β1 axis
    Authors: A Shang, C Gu, W Wang, X Wang, J Sun, B Zeng, C Chen, W Chang, …
    Publication Year: 2020
    Citations: 372

  • Title: Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils
    Authors: A Shang, W Wang, C Gu, C Chen, B Zeng, Y Yang, P Ji, J Sun, J Wu, …
    Publication Year: 2019
    Citations: 147

  • Title: Exosomal KRAS mutation promotes the formation of tumor-associated neutrophil extracellular traps and causes deterioration of colorectal cancer by inducing IL-8 expression
    Authors: A Shang, C Gu, C Zhou, Y Yang, C Chen, B Zeng, J Wu, W Lu, W Wang, …
    Publication Year: 2020
    Citations: 100

  • Title: Tumor microenvironment: lactic acid promotes tumor development
    Authors: Y Gao, H Zhou, G Liu, J Wu, Y Yuan, A Shang
    Publication Year: 2022
    Citations: 80

  • Title: Exosomal miR-183-5p promotes angiogenesis in colorectal cancer by regulation of FOXO1
    Authors: A Shang, X Wang, C Gu, W Liu, J Sun, B Zeng, C Chen, P Ji, J Wu, …
    Publication Year: 2020
    Citations: 77

  • Title: Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer
    Authors: AQ Shang, J Wu, F Bi, YJ Zhang, LR Xu, LL Li, FF Chen, WW Wang, …
    Publication Year: 2017
    Citations: 77

  • Title: Knockdown of long noncoding RNA PVT1 suppresses cell proliferation and invasion of colorectal cancer via upregulation of microRNA-214-3p
    Authors: AQ Shang, WW Wang, YB Yang, CZ Gu, P Ji, C Chen, BJ Zeng, JL Wu, …
    Publication Year: 2019
    Citations: 70

  • Title: IGF2BP2 promotes the progression of colorectal cancer through a YAP‐dependent mechanism
    Authors: J Cui, J Tian, W Wang, T He, X Li, C Gu, L Wang, J Wu, A Shang
    Publication Year: 2021
    Citations: 62

  • Title: miR‐381‐3p restrains cervical cancer progression by downregulating FGF7
    Authors: A Shang, C Zhou, G Bian, W Chen, W Lu, W Wang, D Li
    Publication Year: 2019
    Citations: 62

  • Title: Vaginal microecological characteristics of women in different physiological and pathological period
    Authors: L Shen, W Zhang, Y Yuan, W Zhu, A Shang
    Publication Year: 2022
    Citations: 59

🔚 Conclusion

With a strong academic background, leadership in clinical laboratory medicine, and groundbreaking research in tumor immunology and molecular diagnostics, he continues to make significant contributions to medical science. His extensive experience, prestigious awards, and influential publications highlight his dedication to advancing clinical diagnostics and improving patient outcomes.